RxDoctor Payments Data

Luis Fernandez, MD

Family Medicine · Pocatello, IDNPI 1841299302

Payments from drug & device makers

$752in general payments, 2019–2025

Across 26 payments — averaging $28.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$145
  • Astellas Pharma US Inc$119
  • Xeris Pharmaceuticals, Inc.$67
  • Dexcom, Inc.$64
  • AbbVie$59
  • Novo Nordisk$52
  • plus $246 from 9 others

What the payments were for

  • Food & beverage$66789%
  • Education$8511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$752 in reported general payments places this provider in the 70th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$165,717
Medicare patients
271
Services billed
2,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide83$106,284
JardianceEmpagliflozin52$68,167
EliquisApixaban71$62,473
ShingrixVaricella-Zoster Ge/As01b/Pf277$61,216
ArexvyRsvpref3 Antigen/As01e/Pf185$57,661
MounjaroTirzepatide42$43,813
XareltoRivaroxaban26$32,835
FarxigaDapagliflozin Propanediol17$16,048
TwinrixHepatitis A And B Vaccine/Pf111$16,006
JanuviaSitagliptin Phosphate20$14,369
Boostrix TdapDiphth,pertuss(Acell),tet Vac185$12,821
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$12,421
Lantus SolostarInsulin Glargine,hum.Rec.Anlog65$9,976
Fiasp FlextouchInsulin Aspart (Niacinamide)13$7,995
Novolog FlexpenInsulin Aspart28$7,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKShingrix, Arexvy, Twinrix, Trelegy Ellipta$13$147,304595 claims
Novo NordiskOzempic$52$106,28483 claims
PfizerEliquis$30$62,47371 claims
AbbVieSynthroid$59$2,44944 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 803 family medicine providers in Idaho.

Other family medicine in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →